DocuSign (NASDAQ:DOCU – Free Report) had its price objective lowered by Bank of America from $112.00 to $98.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently ...
Chemed (NYSE:CHE – Free Report) had its price target hoisted by Royal Bank of Canada from $633.00 to $667.00 in a research report released on Friday,Benzinga reports. They currently have an outperform ...